Iron Deficiency Anemia in Infants: Review Article

Fatma mohamed mahmoud

doi:10.58372/2835-6276.1215

Authors

Fatma mohamed mahmoud

DOI:

https://doi.org/10.58372/2835-6276.1215

Keywords:

Anemia, iron deficiency, infants, cognitive development, motor development, growth

Abstract

Iron deficiency is the most common nutritional deficiency worldwide, with infants being particularly vulnerable. Iron deficiency anemia (IDA) in infancy can significantly impact growth, development, and overall health. This comprehensive review summarizes the current understanding of IDA in infants, including its etiological factors, clinical features, diagnostic approach, treatment strategies, and preventive measures. Risk factors for IDA in infants include inadequate dietary iron intake, increased physiological requirements during this period of rapid growth, prematurity, low birth weight, and chronic blood loss. IDA in infancy has been associated with impairments in cognitive development, motor function, and social-emotional wellbeing, with some effects persisting into later childhood. Prompt diagnosis involves assessment of hemoglobin, red cell indices, and iron status markers such as serum ferritin. Oral iron supplementation remains the mainstay of treatment, with parenteral iron therapy reserved for severe or refractory cases. Prevention strategies focus on optimizing maternal iron status, ensuring adequate iron intake through exclusive breastfeeding in the first 6 months and timely introduction of iron-rich complementary foods, iron supplementation in high-risk populations, and limiting excessive cow's milk intake. Routine screening for IDA in infants, especially in at-risk groups, coupled with appropriate interventions, is crucial to address this preventable condition. Continued research is needed to explore innovative strategies for effective prevention and treatment of IDA in infancy, as well as to elucidate the long-term impact on child health outcomes. A coordinated effort from healthcare providers, policymakers, and community stakeholders is essential to reduce the global burden of IDA in infants and ensure optimal child growth, development, and well-being.

References

Aksu, T., & Ünal, Ş. (2023). Iron deficiency anemia in infancy, childhood, and adolescence. Turkish Archives of Pediatrics, 58(4), 358-362.

Baker, R. D., Greer, F. R., & Committee on Nutrition American Academy of Pediatrics. (2010). Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics, 126(5), 1040-1050.

Camaschella, C. (2015). Iron-deficiency anemia. New England Journal of Medicine, 372(19), 1832-1843.

Dewey, K. G. (2001). Nutrition, growth, and complementary feeding of the breastfed infant. Pediatric Clinics of North America, 48(1), 87-104.

Dewey, K. G., & Chaparro, C. M. (2007). Session 4: Mineral metabolism and body composition iron status of breast-fed infants. Proceedings of the Nutrition Society, 66(3), 412-422.

Hoffbrand, V., Vyas, P., Campo, E., Haferlach, T., & Gomez, K. (Eds.). (2019). Color atlas of clinical hematology: Molecular and cellular basis of disease (5th ed.). John Wiley & Sons.

Jáuregui-Lobera, I. (2014). Iron deficiency and cognitive functions. Neuropsychiatric Disease and Treatment, 10, 2087-2095.

Jullien, S. (2021). Screening of iron deficiency anaemia in early childhood. BMC pediatrics, 21(Suppl 1), 337.

Kato, S., Gold, B. D., & Kato, A. (2022). Helicobacter pylori-associated iron deficiency anemia in childhood and adolescence-pathogenesis and clinical management strategy. Journal of Clinical Medicine, 11(24), 7351.

Lennox, A., Sommerville, J., Ong, K., Henderson, H., & Allen, R. (2013). Diet and nutrition survey of infants and young children, 2011.

Lukowski, A. F., Koss, M., Burden, M. J., Jonides, J., Nelson, C. A., Kaciroti, N., Jimenez, E., & Lozoff, B. (2010). Iron deficiency in infancy and neurocognitive functioning at 19 years: Evidence of long-term deficits in executive function and recognition memory. Nutritional Neuroscience, 13(2), 54-70.

Maguire, J. L., deVeber, G., & Parkin, P. C. (2007). Association between iron-deficiency anemia and stroke in young children. Pediatrics, 120(5), 1053-1057.

Mantadakis, E. (2016). Advances in pediatric intravenous iron therapy. Pediatric Blood & Cancer, 63(1), 11-16.

Mattiello, V., Schmugge, M., Hengartner, H., von der Weid, N., Renella, R., & SPOG Pediatric Hematology Working Group. (2020). Diagnosis and management of iron deficiency in children with or without anemia: Consensus recommendations of the SPOG Pediatric Hematology Working Group. European Journal of Pediatrics, 179(4), 527-545.

Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003). Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood, 101(7), 2461-2463.

Özdemir, N. (2015). Iron deficiency anemia from diagnosis to treatment in children. Turkish Archives of Pediatrics, 50(1), 11-19.

Pivina, L., Semenova, Y., Doşa, M. D., Dauletyarova, M., & Bjørklund, G. (2019). Iron deficiency, cognitive functions, and neurobehavioral disorders in children. Journal of Molecular Neuroscience, 68(1), 1-10.

Powers, J. M., & Buchanan, G. R. (2019). Disorders of iron metabolism: New diagnostic and treatment approaches to iron deficiency. Hematology/Oncology Clinics of North America, 33(3), 393-408.

Powers, J. M., & O'Brien, S. H. (2019). How I approach iron deficiency with and without anemia. Pediatric Blood & Cancer, 66(3), e27544.

Powers, J. M., Nagel, M., Raphael, J. L., Mahoney, D. H., Buchanan, G. R., & Thompson, D. I. (2020). Barriers to and facilitators of iron therapy in children with iron deficiency anemia. The Journal of Pediatrics, 219, 202-208.

Stoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: Two open-label, randomised controlled trials. The Lancet Haematology, 4(11), e524-e533.

Tansarli, G. S., Karageorgopoulos, D. E., Kapaskelis, A., Gkegkes, I., & Falagas, M. E. (2013). Iron deficiency and susceptibility to infections: Evaluation of the clinical evidence. European Journal of Clinical Microbiology & Infectious Diseases, 32(10), 1253-1258.

Wang, B., Zhan, S., Gong, T., & Lee, L. (2013). Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database of Systematic Reviews, (6).

Wong, C. (2017). Iron deficiency anaemia. Paediatrics and Child Health, 27(11), 527-529.

World Health Organization. (2008). Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. https://www.who.int/publications/i/item/9789241596657

World Health Organization. (2020). WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. https://www.who.int/publications/i/item/9789240000124

Bakthavatchalam, P., & Thangarajan, R. (2022). Iron and Neurodevelopmental Disorders. In Brain-Iron Cross Talk (pp. 247-261). Singapore: Springer Nature Singapore.